News + Filings Transactions Holdings
|
BIOTECHNOLOGY VALUE FUND L P
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Principia Biopharma Inc.
| PRNB | Common | 5,231,900 | 0 | 528,788,133 | 9,522,058 | | |
Hist
| 08/25/2020 |
FIVE PRIME THERAPEUTICS, INC.
| FPRX | Common | 6,338,678 | -1,444,323 | 240,869,764 | 209,348,610 | | |
Hist
| 03/04/2021 |
Protagonist Therapeutics, Inc
| PTGX | Common | 4,891,945 | 616,980 | 167,304,519 | 81,121,225 | | |
Hist
| 12/31/2021 |
Xenon Pharmaceuticals Inc.
| XENE | COM | 5,157,486 | 1,658,140 | 161,119,863 | 107,299,921 | | |
Hist
| 12/31/2021 |
XOMA Corp
| XOMA | COMMON STOCK | 3,530,543 | -651,700 | 144,081,460 | 66,709,964 | | |
Hist
| 03/31/2021 |
Merus N.V.
| MRUS | COM | 4,135,071 | -925,000 | 131,495,258 | 24,828,961 | | |
Hist
| 12/31/2021 |
Syndax Pharmaceuticals Inc
| SNDX | Common | 4,931,879 | 1,221,190 | 107,958,831 | 25,433,108 | | |
Hist
| 12/31/2021 |
Repare Therapeutics Inc.
| RPTX | Common | 4,858,761 | 1,136,363 | 102,471,269 | -825,275 | | |
Hist
| 12/31/2021 |
ARQULE INC
| ARQL | COM | 4,902,383 | -3,767,967 | 97,851,565 | 73,834,695 | | |
Hist
| 12/31/2019 |
ESSA Pharma Inc.
| EPIX | COM NEW | 4,565,242 | 859,953 | 64,826,436 | 20,622,339 | | |
Hist
| 12/31/2021 |
ABBOTT BIOTHERAPEUTICS CORP
| FACT | COM | 3,683,521 | 1,876,900 | 59,488,864 | 43,247,341 | | |
Hist
| 09/08/2009 |
LEXICON PHARMACEUTICALS, INC.
| LXRX | COM NEW | 14,360,000 | 14,360,000 | 56,578,400 | 56,578,400 | | |
Hist
| 12/31/2021 |
Spero Therapeutics, Inc.
| SPRO | Common | 3,411,520 | 643,242 | 54,618,435 | 941,525 | | |
Hist
| 12/31/2021 |
CYTOKINETICS INC
| CYTK | COM NEW | 2,728,035 | -4,478,423 | 54,560,700 | -21,899,819 | | |
Hist
| 01/11/2021 |
APPLIED BIOSYSTEMS INC.
| CRA | Common Stock | 8,017,692 | 2,437,530 | 52,756,413 | 19,554,449 | | |
Hist
| 02/09/2010 |
Forte Biosciences, Inc.
| TOCA | Common | 1,344,262 | 254,279 | 48,944,579 | 47,571,201 | | |
Hist
| 12/31/2020 |
Revolution Medicines, Inc.
| RVMD | Common | 1,810,549 | -1,946,500 | 45,571,518 | -63,382,903 | | |
Hist
| 12/31/2021 |
ChemoCentryx, Inc.
| CCXI | Common | 4,105,215 | -2,582,308 | 44,828,948 | -28,131,928 | | |
Hist
| 02/12/2019 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 2,202,315 | 2,202,315 | 43,539,768 | 43,539,768 | | |
Hist
| 12/31/2021 |
Kura Oncology, Inc.
| KURA | Common | 1,245,912 | -1,188,784 | 40,691,486 | 13,909,830 | | |
Hist
| 12/31/2020 |
SUTRO BIOPHARMA, INC.
| STRO | Common | 1,854,162 | 1,854,162 | 40,253,857 | 40,253,857 | | |
Hist
| 12/31/2020 |
NEKTAR THERAPEUTICS
| NKTR | Common | 7,415,400 | 6,889,900 | 38,041,002 | 33,143,342 | | |
Hist
| 12/14/2011 |
LIGAND PHARMACEUTICALS INC
| LGND | COM | 3,476,044 | 3,476,044 | 36,811,306 | 36,811,306 | | |
Hist
| 11/21/2011 |
CytomX Therapeutics, Inc.
| CTMX | Common | 5,576,471 | 2,387,523 | 36,525,885 | 13,948,133 | | |
Hist
| 12/31/2020 |
GLYCOMIMETICS INC
| GLYC | COM | 9,544,262 | 2,182,461 | 35,886,425 | -3,057,502 | | |
Hist
| 12/31/2020 |
Verastem, Inc.
| VSTM | Common | 17,062,158 | 5,881,164 | 34,977,424 | 11,161,907 | | |
Hist
| 12/31/2021 |
Oncternal Therapeutics, Inc.
| GTXI | COM NEW | 2,218,514 | 2,218,514 | 28,197,313 | 28,197,313 | | |
Hist
| 12/31/2017 |
Celldex Therapeutics, Inc.
| CLDX | COMMON | 2,740,000 | 2,740,000 | 28,085,000 | 28,085,000 | | |
Hist
| 06/16/2020 |
PIERIS PHARMACEUTICALS, INC.
| PIRS | COM | 7,406,643 | 1,805,061 | 27,997,111 | 13,993,156 | | |
Hist
| 12/31/2021 |
Arcus Biosciences, Inc.
| RCUS | Common | 2,752,222 | 2,752,222 | 27,549,742 | 27,549,742 | | |
Hist
| 02/04/2020 |
Cogent Biosciences, Inc.
| COGT | Common | 3,114,532 | 282 | 26,722,685 | -8,250,343 | | |
Hist
| 12/31/2021 |
AVADEL PHARMACEUTICALS PLC
| FLML | SPONSORED ADR | 3,538,774 | -288,257 | 26,186,928 | 11,184,966 | | |
Hist
| 12/31/2009 |
LIGAND PHARMACEUTICALS INC
| LGND | CL B | 11,300,486 | 0 | 24,522,055 | -4,181,180 | | |
Hist
| 12/31/2009 |
Ovid Therapeutics Inc.
| OVID | COM | 6,631,051 | 2,109,000 | 24,269,647 | 13,823,709 | | |
Hist
| 04/13/2021 |
Oncternal Therapeutics, Inc.
| GTXI | COM STK | 2,390,000 | 2,390,000 | 23,541,500 | 23,541,500 | | |
Hist
| 02/19/2009 |
<< Prev Next >> |
|
|
|
|